IGF-1LR3 0.1 mg
A supplier name potentially corresponding to Long [Arg3]-IGF-I, a modified IGF-I analogue.
CAD $37.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0082 Listed amount per vial: 0.1 mg Sales unit: 1 vial
Read the research in context.
A supplier name potentially corresponding to Long [Arg3]-IGF-I, a modified IGF-I analogue.
- Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Candidate has an N-terminal extension and Glu-to-Arg substitution at IGF-I residue 3. Do not merge with native IGF-I, DES IGF-I, or MGF. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for IGF-1LR3, product reference MRD-0082.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 0.1 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.